Reports and Disclosures

Countries of Registration:

England and Wales

Company Registered Number:

2992058

Location of Operations:

Silence is headquartered in the U.K. with research and development operations carried out in Germany.

Nominated Advisors and Brokers:

N+1 Singer One Bartholomew Lane London EC2N 2AX Tel: +44 20 7496 3000

Constitutional Documents:

• Most Recent AIM Admission Document
• Summary of Articles
• Memorandum of Association
• Full Articles of Association

Disclosure Forms:

• Public Opening Position Disclosure

Meeting Notification and Proxy:

• Notice of Annual General Meeting
• Annual General Meeting - Proxy

Annual and Interim Reports:

• Interim Results June 2012
• Annual Report 2011
• Interim Results June 2011
• Annual Report 2010
• Interim Results June 2010
• Annual Report 2009
• Interim Report June 2009
• Annual Report 2008
• Interim Report June 2008
• Annual Report 2007

Recent Circulars:

• Subscriptions and Open Offer Circular July 2012
• Financing Circular April 2011

Fundraising Presentations:

• March 2013 Fundraising Presentation
• Silence Therapeutics Presentation March 2013
• April 2011 Fundraising Presentation

Committee Composition:

Remuneration Committee – Assisting the board in the discharging of its responsibilities related to remuneration of the company’s executive officers.

• Jerry Randall

• David Mack

Audit Committee – Assisting board oversight of accounting and financial reporting processes and the audits of the company’s financial statements

• Jerry Randall (Chairman)

 

Nominations and Governance Committee – Recommending to the board those persons to be nominated for election as directors at any shareholders meeting

• David Mack